Cardiovascular risk in anti-VEGF treatment of neovascular age-related macular degeneration.


Journal article


David D. Chong, Christopher M. Maatouk, Jonathan C Markle, Jacqueline K. Shaia, Rishi P. Singh, Katherine E. Talcott
Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie, 2024

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Chong, D. D., Maatouk, C. M., Markle, J. C., Shaia, J. K., Singh, R. P., & Talcott, K. E. (2024). Cardiovascular risk in anti-VEGF treatment of neovascular age-related macular degeneration. Canadian Journal of Ophthalmology-Journal Canadien D Ophtalmologie.


Chicago/Turabian   Click to copy
Chong, David D., Christopher M. Maatouk, Jonathan C Markle, Jacqueline K. Shaia, Rishi P. Singh, and Katherine E. Talcott. “Cardiovascular Risk in Anti-VEGF Treatment of Neovascular Age-Related Macular Degeneration.” Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie (2024).


MLA   Click to copy
Chong, David D., et al. “Cardiovascular Risk in Anti-VEGF Treatment of Neovascular Age-Related Macular Degeneration.” Canadian Journal of Ophthalmology-Journal Canadien D Ophtalmologie, 2024.


BibTeX   Click to copy

@article{david2024a,
  title = {Cardiovascular risk in anti-VEGF treatment of neovascular age-related macular degeneration.},
  year = {2024},
  journal = {Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie},
  author = {Chong, David D. and Maatouk, Christopher M. and Markle, Jonathan C and Shaia, Jacqueline K. and Singh, Rishi P. and Talcott, Katherine E.}
}


Share


Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in